Signature phaco machine offers good stability

Article

Anterior chamber fluctuations during phacoemulsification can cause an increase in retinal thickness and alterations of the blood aqueous barrier. In order to avoid these complications, it is better to use a machine that offers good anterior chamber stability.

Anterior chamber fluctuations during phacoemulsification can cause an increase in retinal thickness and alterations of the blood aqueous barrier. In order to avoid these complications, it is better to use a machine that offers good anterior chamber stability, according to Alessandro Franchini and colleagues from the University of Florence, Italy.

The researchers used a micro silicon sensor interfaced with a control unit, inserted in the anterior chamber during phacoemulsification to continuously monitor the anterior chamber tension in three groups of 20 patients being operated on with three different phacoemulsifiers: Sovereign WhiteStar (AMO), Signature (AMO) and Legacy Everest (Alcon).

The average anterior chamber variation during phacoemulsification was 7.2 mmHg using the Signature, 15.5 mmHg with the WhiteStar and 16.3 mmHg using the Legacy (Signature vs WhiteStar: p<0.05; Signature vs Legacy: p<0.001; WhiteStar vs Legacy: p=0.132).

Anterior fluctuations can cause complications so it is best to use a machine that can guarantee anterior chamber stability. With this in mind the authors recommend using AMOs Signature system to control fluidics thus reducing fluctuations.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.